MedWatch Safety Alerts

⚠ ARGATROBAN — Par Health USA, LLC

Date: 10/13/2026. Voluntary: Firm initiated. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

⚠ ARGATROBAN — Par Health USA, LLC

Date: 10/13/2026. Voluntary: Firm initiated. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

⚠ Greenwich Rx

Date: 10/01/2026. Voluntary: Firm initiated. Microbial Contamination of Sterile Products

⚠ THYROID — VITRUVIAS THERAPEUTICS INC

Date: 08/21/2026. Voluntary: Firm initiated. Superpotent Drug

⚠ SODIUM CHLORIDE — B BRAUN MEDICAL INC

Date: 08/19/2026. Voluntary: Firm initiated. Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene

⚠ SODIUM CHLORIDE — Baxter Healthcare Corporation

Date: 08/17/2026. Voluntary: Firm initiated. Presence of particulate matter: Particulates identified as fiberglass

⚠ Baxter Healthcare Corporation

Date: 08/17/2026. Voluntary: Firm initiated. Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

⚠ LACTATED RINGERS — B BRAUN MEDICAL INC

Date: 08/12/2026. Voluntary: Firm initiated. Presence of Particulate matter.

⚠ EPINEPHRINE — American Regent, Inc.

Date: 08/11/2026. Voluntary: Firm initiated. Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

⚠ TYENNE — Fresenius Kabi USA, LLC

Date: 08/10/2026. Voluntary: Firm initiated. Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

⚠ OPTIMAL BALANCE PHARMACY

Date: 08/05/2026. Voluntary: Firm initiated. Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

⚠ MORPHINE SULFATE — Fresenius Kabi USA, LLC

Date: 08/04/2026. Voluntary: Firm initiated. Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

⚠ OPTIRAY — Liebel-Flarsheim Company LLC

Date: 07/31/2026. Voluntary: Firm initiated. Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

⚠ PAPAVERINE HYDROCHLORIDE — American Regent, Inc.

Date: 07/24/2026. Voluntary: Firm initiated. Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

⚠ CEFAZOLIN — Baxter Healthcare Corporation

Date: 07/24/2026. Voluntary: Firm initiated. Presence of Particulate Matter

⚠ Sunny Pharmtech Inc.

Date: 07/17/2026. Voluntary: Firm initiated. Presence of Particulate Matter; identified as stainless steel

⚠ Sunny Pharmtech Inc.

Date: 07/17/2026. Voluntary: Firm initiated. Presence of Particulate Matter; identified as stainless steel

⚠ Victory Medical Center Pharmacy

Date: 07/01/2026. Voluntary: Firm initiated. Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

⚠ CETIRIZINE HYDROCHLORIDE — JB Chemicals and Pharmaceuticals Ltd

Date: 06/24/2026. Voluntary: Firm initiated. Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

⚠ Haleon US Holdings LLC

Date: 06/04/2026. Voluntary: Firm initiated. Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.